The Receptor for advanced glycation end-products (RAGE) is a multi-ligand cell membrane receptor implicated in diverse chronic inflammatory states such as cardiovascular disease, cancer, neurodegeneration, and diabetes (50–52). Here, AGER is linked to cancer.